Straits Times Index
3,297.55 -26.98 (-0.81%) Nikkei
38,814.56 +94.09 (+0.24%) Hang Seng
17,941.78 -170.85 (-0.94%) FTSE 100
8,146.86 -16.81 (-0.21%) Bitcoin USD
66,069.49 +117.80 (+0.18%) CMC Crypto 200
1,403.34 -14.54 (-1.03%)
CBRE Dec 2024 80.000 call
- PR Newswire
MainStay CBRE Global Infrastructure Megatrends Term Fund (NYSE: MEGI) Declares Monthly Distribution for June 2024 and Availability of 19(a) Notice
MainStay CBRE Global Infrastructure Megatrends Term Fund (the "Fund") (NYSE: MEGI) today announced the Fund's monthly distributions for June 2024 of $0.1250 per common share. The Fund's current annualized distribution rate is 11.79% based upon the closing price of $12.72 on June 12, 2024, and 10.32% based upon the Fund's closing NAV of $14.54 as of the same date.
- Business Wire
CBRE Expands Climate Risk Assessment Capabilities with Climate X Agreement, Enabling Enhanced Actionable Sustainability Insights
DALLAS, June 13, 2024--CBRE Group, Inc. (NYSE:CBRE) today announced expanded capabilities to provide comprehensive climate risk data for property investors and occupiers to accelerate their sustainability planning, reporting and decision making.
- EdgeProp
Ageing population, rising healthcare needs to fuel demand for Singapore life sciences real estate: CBRE
Life sciences real estate in Singapore are predominantly located in three clusters: Biopolis, Singapore Science Park and Tuas Biomedical Park (Picture: Samuel Isaac Chua/The Edge Singapore)The biomedical manufacturing sector is poised to see sustained growth, which in turn, will propel momentum for Singapore’s biomedical sector and consequently demand for R&D and specialised manufacturing spaces, according to CBRE.In a June research report, the consultancy highlights biomedical manufacturing’s s
